Sunday, 25 June 2017    HomeAbout UsContact Us    









You are here: Home Articles


Susceptibility To Asymptomatic Reinfection Amongst Fully Vaccinated Individuals
Posted by vaccinesme, in Articles
Topics: Herd Immunity Measles Reinfection

  Mail To Friend    Printer Friendly Bookmark and Share

Damien B, Huiss S, Schneider F, Muller CP. Estimated susceptibility to asymptomatic secondary immune response against measles in late convalescent and vaccinated persons. J Med Virol 1998 Sep;56(1):85-90

Serological evidence indicates that measles virus (MV) could circulate in seropositive, fully protected populations. Among individuals fully protected against disease, those prone to asymptomatic secondary immune response are the most likely to support subclinical MV transmission. The serological characteristics of protected subjects who developed secondary immune response after reexposure to measles have been described recently [Huiss et al. (1997): Clinical and Experimental Immunology 109:416-420]. On the basis of these data, a threshold of susceptibility was defined to estimate frequencies of secondary immune response competence in different populations. Among measles, late convalescent adults (n = 277) and vaccinated high school children (n = 368), 3.2-3.9% and 22.2-33.2%, respectively, were considered susceptible to secondary immune response. A second vaccination did not seem to lower this incidence. Even when estimates of symptomatic secondary immune response (e.g., secondary vaccine failure) were taken into account, susceptibility to subclinical secondary immune response was still 5-8 times higher after vaccination than after natural infection. Although viral transmission between protected individuals has never been directly demonstrated, the data describe a population in which protected but infectious persons could potentially be of epidemiological importance.

The research data from the above paper illustrates that transmission of disease via "protected individuals" (through vaccination) is something that can occur, an in fact it does occur as can be seen from instances of measles outbreak in highly or fully vaccinated populations.

Also re-vaccination does not protect a person from re-infection as the authors of the paper state, and that susceptibility to re-infection is 5-8 times higher after vaccination than after a natural infection - illustrating the difference between artificial and natural immunity.

Artificial Herd Immunity (through vaccination) is something that can never be achieved. In fact vaccination policies are resulting in the pushing of disease occurrence into other age groups in which it is much more dangerous - such as measles now being found in infants and adults.

The original concept of Herd Immunity was coined by A.W. Hedrich in the 1930s after he studied measles for a few decades. From his observations he concluded that when 68% of a population get the disease naturally, the outbreaks died out and stopped. This protection stopped when the number who contracted this disease or who were exposed to it fell below 68% of the population.

Unfortunately, the concept of Herd Immunity has been hijacked from its original intended meaning and is now applied to how many people are required to be vaccinated against a disease for outbreaks to completely stop. The two situations are not the same. The underlying assumption that vaccination provides the same level and type of immunity (on an individual and population level) as natural disease. There are numerous problems with this. Firstly, an artificial vaccine-induced antibody response is not the same as the more complex and complete, holistic response to a natural infection. Secondly, antibodies on their own do not necessitate protection from disease. People with high levels of antibody to a particular disease still get the disease, and people with no detectable antibodies can be immune to the disease. Thirdly, in artificially-induced immunity, antibodies wane over time and thus "booster" shots always have to be recommended whereas in a natural infection, the protection is usually life-long, if not long-term.


Link to this article:   Show: HTML LinkFull LinkShort Link
Share or Bookmark this page: You will need to have an account with the selected service in order to post links or bookmark this page.

                 
  
Subscribe via RSS or email:
Follow us through RSS or email. Click the RSS icon to subscribe to our feed.

     
  

Related Articles:
Add a Comment
You must be registered and logged in to comment.







Topics
Basics
Vaccines
Nutrition
Articles
News

Latest Articles
Effective or Ineffective: Attribute Framing and the Human Papillomavirus (HPV) Vaccine
CNS Demyelination and Quadrivalent HPV Vaccination
Pertussis Infection in Fully Vaccinated Children in Day-Care Centers, Israel
Chemoprevention Trial of Human Hepatitis With Selenium Supplementation in China
Protective Role of Selenium Against Hepatitis B Virus and Primary Liver Cancer in Qidong
An Increase in Selenium Intake Improves Immune Function and Poliovirus Handling in Adults With Marginal Selenium Status
Nutritional and Food Protection Against Epidemic Emerging Neuropathy. Epidemiological Findings in the Unique Disease-Free Urban Area of Cuba
Diphtheria-Tetanus-Pertussis Vaccine Administered Simultaneously With Measles Vaccine Is Associated With Increased Morbidity and Poor Growth in Girls
Children Vaccinated With MMR and Higher Risk of Multiple Sclerosis
A Possible Central Mechanism in Autism Spectrum Disorders

Pages
No pages found.

Most Popular
What Is Vaccine Failure?
Measles Outbreak in Previously Immunized Children, Florida, US
Antibody Response To Vaccine Does Not Equal Immunity or Protection
Explaining the Reemergence of Pertussis in Vaccinated Populations
Explosive School-Based Measles Outbreak in Vaccinated Students - Finland
Discontinuation of BCG Vaccine in Japan Leads To Significant Drop in Type 2 Diabetes
The Myth Of Vaccines Causing 20th Century Mortality Decline: Excellent Paper by Mckinlay and Mckinlay
Protective Effect of Childhood Measles Against Degenerative Diseases in Later Life
BCG (Tuberculosis) Vaccine Induced Inflammation Linked to Type 2 Diabetes Epidemic
The Role of The Measles Vaccine in Preventing Measles Deaths in the 20th Century

Archives (View more)
2011 • December
2011 • October
2010 • February
2009 • June
2009 • May
2009 • April
2009 • March
2009 • February
2009 • January


Popular Topics
mortality declinemeaslesmortality ratesmeasles outbreaksVitamin AVitamin Cmeasles deathsmeasles outbreakvaccine failuresecondary vaccine failuremumpsMMRmumps outbreakrubini strainantibodiesantibodymumps vaccineaseptic meningitisenterovirusechovirusurabe strainrubellapregnancyautismparkinsons diseasemeasles vaccineadverse reactionsGuillain-Barre Syndromebrain injurydeathGeorge Fishervaccine deathvaccine compensationpoliovaccine damagereverse transcriptaseretroviruseschicken poxvaricellapertussiswhooping coughDTPdiptheriatetanusdiabetesBCGHIBHemophilus BasthmaallergiesmercurythimerosalgardasilHPVASDBailey BanksHerd Immunitypneumoniaprevnarpneumococcalotitispediacelpsoriasisflu vaccineHepatitis BHepatitis APseudolymphomaaluminium hydroxideallergyatopyCRSmeningitisinfectionsvaccination policyvaccination scienceOPVoral polio vaccineseroconversionvaccine marketingcervical cancerinfluenzaDPTchickenpoxvaccinationimmunizationnatural immunityvaccine efficacyreinfectionmultiple sclerosisprimary vaccine failureGuillain-BarreSIDSsudden deatharthritisadjuvantsaluminiumchronic fatigueexcitotoxinsimmunoexcitotoxinsSelenium
Copyright © 2017 . All rights reserved. RSSTagsPrivacyLegal and Terms of UseSitemap